Prognostic factors influencing prostate cancer-specific survival in non-castrate patients with metastatic prostate cancer
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prognostic factors influencing prostate cancer-specific survival in non-castrate patients with metastatic prostate cancer
Authors
Keywords
-
Journal
PROSTATE
Volume 74, Issue 3, Pages 297-305
Publisher
Wiley
Online
2013-11-08
DOI
10.1002/pros.22750
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Metastasis-free survival is associated with overall survival in men with PSA-recurrent prostate cancer treated with deferred androgen deprivation therapy
- (2013) M. T. Schweizer et al. ANNALS OF ONCOLOGY
- Differences in Time to Disease Progression Do Not Predict for Cancer-specific Survival in Patients Receiving Immediate or Deferred Androgen-deprivation Therapy for Prostate Cancer: Final Results of EORTC Randomized Trial 30891 with 12 Years of Follow-up
- (2013) Urs E. Studer et al. EUROPEAN UROLOGY
- Colorectal cancer pulmonary oligometastases: pooled analysis and construction of a clinical lung metastasectomy prognostic model
- (2012) S. Salah et al. ANNALS OF ONCOLOGY
- Salvage Stereotactic Body Radiotherapy for Patients With Limited Prostate Cancer Metastases: Deferring Androgen Deprivation Therapy
- (2012) Patrick Berkovic et al. Clinical Genitourinary Cancer
- Stereotactic body radiotherapy for oligometastases
- (2012) Alison C Tree et al. LANCET ONCOLOGY
- The natural history of metastatic progression in men with prostate-specific antigen recurrence after radical prostatectomy: long-term follow-up
- (2011) Emmanuel S. Antonarakis et al. BJU INTERNATIONAL
- Androgen Deprivation Causes Epithelial-Mesenchymal Transition in the Prostate: Implications for Androgen-Deprivation Therapy
- (2011) Y. Sun et al. CANCER RESEARCH
- Prognostic models for outcome following liver resection for colorectal cancer metastases: A systematic review
- (2011) L. Spelt et al. EJSO
- High-Dose Salvage Intensity-Modulated Radiotherapy With or Without Androgen Deprivation After Radical Prostatectomy for Rising or Persisting Prostate-Specific Antigen: 5-Year Results
- (2011) Piet Ost et al. EUROPEAN UROLOGY
- Long-Term Risk of Clinical Progression After Biochemical Recurrence Following Radical Prostatectomy: The Impact of Time from Surgery to Recurrence
- (2011) Stephen A. Boorjian et al. EUROPEAN UROLOGY
- Pelvic/Retroperitoneal Salvage Lymph Node Dissection for Patients Treated With Radical Prostatectomy With Biochemical Recurrence and Nodal Recurrence Detected by [11C]Choline Positron Emission Tomography/Computed Tomography
- (2011) Patrizio Rigatti et al. EUROPEAN UROLOGY
- EAU Guidelines on Prostate Cancer. Part II: Treatment of Advanced, Relapsing, and Castration-Resistant Prostate Cancer
- (2011) Nicolas Mottet et al. EUROPEAN UROLOGY
- MicroRNA Expression Characterizes Oligometastasis(es)
- (2011) Yves A. Lussier et al. PLoS One
- Long-term overall survival and metastasis-free survival for men with prostate-specific antigen-recurrent prostate cancer after prostatectomy: analysis of the Center for Prostate Disease Research National Database
- (2010) Emmanuel S. Antonarakis et al. BJU INTERNATIONAL
- The Role of Choline Positron Emission Tomography/Computed Tomography in the Management of Patients with Prostate-Specific Antigen Progression After Radical Treatment of Prostate Cancer
- (2010) Maria Picchio et al. EUROPEAN UROLOGY
- The Number of Pulmonary Metastases: Influence on Practice and Outcome
- (2010) Mariano García-Yuste et al. Journal of Thoracic Oncology
- Monoclonal antibody targeting of N-cadherin inhibits prostate cancer growth, metastasis and castration resistance
- (2010) Hiroshi Tanaka et al. NATURE MEDICINE
- Review of major adverse effects of androgen-deprivation therapy in men with prostate cancer
- (2009) Lockwood G. Taylor et al. CANCER
- Potential Benefits of Intermittent Androgen Suppression Therapy in the Treatment of Prostate Cancer: A Systematic Review of the Literature
- (2009) Per-Anders Abrahamsson EUROPEAN UROLOGY
- The COMPARE Registry: Design and Baseline Patterns of Care for Men With Biochemical Failure After Definitive Treatment of Localized Prostate Cancer
- (2009) Oliver Sartor et al. UROLOGY
- Intensity-Modulated Radiotherapy as Primary Therapy for Prostate Cancer: Report on Acute Toxicity After Dose Escalation With Simultaneous Integrated Boost to Intraprostatic Lesion
- (2008) Valérie Fonteyne et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Timing of Androgen Deprivation Therapy and its Impact on Survival After Radical Prostatectomy: A Matched Cohort Study
- (2008) Sameer A. Siddiqui et al. JOURNAL OF UROLOGY
- The Natural History of Men Treated With Deferred Androgen Deprivation Therapy in Whom Metastatic Prostate Cancer Developed Following Radical Prostatectomy
- (2007) Danil V. Makarov et al. JOURNAL OF UROLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started